Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individuals

31 Oct 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Neurodegenerative Diseases
Share to Hereditary Neurological Disorders
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36318270
DOI: 10.1016/j.gim.2022.09.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Brain monoamine vesicular transport disease caused by homozygous SLC18A2 variants: A study in 42 affected individualsPMID 36318270Read ↗

A novel missense variant in SLC18A2 causes recessive brain monoamine vesicular transport disease and absent serotonin in plateletsSemantic proximity Read ↗

Genetic variants in the vesicular monoamine transporter 1 (VMAT1/SLC18A1) and neuropsychiatric disorders.Semantic proximity Read ↗

SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.Semantic proximity Read ↗

A case report of infantile parkinsonism-dystonia-2 caused by homozygous mutation in the SLC18A2 gene.Semantic proximity Read ↗

Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditionsSemantic proximity Read ↗

PharmGKB submission update: VI. PMT submissions of genetic variations in neurotransmitter transporters (SLC6, SLC17, and SLC18) to the PharmGKB network.Semantic proximity Read ↗

Pathogenic mechanisms underlying SLC6A1 variant-mediated neurodevelopmental disorders.Semantic proximity Read ↗

Polyglutamine disorders: Pathogenesis and potential drug interventionsSemantic proximity Read ↗

The effect of rare human sequence variants on the function of vesicular monoamine transporter 2.Semantic proximity Read ↗

Diagnostic approach to neurotransmitter monoamine disorders: experience from clinical, biochemical, and genetic profiles.Semantic proximity Read ↗

SLC1A2 rs3794087 variant and risk for essential tremor: a systematic review and meta-analysis.Semantic proximity Read ↗

Thr136Ile polymorphism of human vesicular monoamine transporter-1 (SLC18A1 gene) influences its transport activity in vitro.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.